amwell Balanced Scorecard

amwell Balanced Scorecard

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

amwell Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Dive Deeper Into the Growth Paths Behind the Analysis

This amwell Balanced Scorecard Analysis gives you a structured view of the company's financial, customer, internal process, and learning and growth priorities. The page already shows a real preview of the actual report content, so you can review the style and substance before buying. Purchase the full version to get the complete ready-to-use analysis.

Benefits

Icon

Access Lift

Amwell can use an Access Lift scorecard to show whether video, audio, and text care widen reach without lowering quality. That matters because Medicare telehealth flexibilities were extended through September 30, 2025, keeping virtual access central to care delivery. Track rural share, new-patient share, and repeat-visit rates so Company Name can prove access gains with stable outcomes.

Icon

Channel Clarity

A Balanced Scorecard gives Amwell a clean read on video, audio, and text visits, so leaders can compare completion rates and friction by channel. In 2025, that matters because every failed visit raises rework and lowers capacity. It also helps show which format gives the best patient experience and where to shift demand.

Explore a Preview
Icon

Renewal Insight

Renewal insight connects usage and service quality to retention across health systems, health plans, employers, and consumers. For Amwell, that matters more than one-time visit volume because platform value shows up in repeat contracts and lower churn. In fiscal 2025, this lens helps track whether better care access is turning into longer customer life, not just more sessions.

Icon

Cost Control

Amwell's cost control scorecard should track whether virtual visits reduce avoidable ER use, duplicate tests, and low-value admin work. That matters because U.S. health spending reached about $4.9 trillion in 2023, so even small waste cuts can have a real margin impact. It also keeps Amwell tied to its core value: better outcomes with less care friction. If these savings do not show up in the data, the model is not proving its worth.

Icon

Workflow Quality

Workflow Quality in Amwell's 2025 scorecard should track wait times, visit completion, technical reliability, and care continuity. In telehealth, a short delay or failed visit can quickly weaken trust and lower repeat use, so these signals matter more than headline volume. That makes the scorecard useful for spotting where service friction is hurting patient retention and clinician efficiency.

Icon

Amwell's 2025 Telehealth Scorecard: More Access, Better Retention, Lower Cost

Amwell's benefits scorecard ties access, retention, and cost savings to 2025 results. With Medicare telehealth flexibilities extended through September 30, 2025, the model can show whether video, audio, and text care lift reach without hurting quality.

Benefit 2025 signal
Access Rural, new, repeat visits
Retention Repeat use, churn
Efficiency Wait, completion, rework

What is included in the product

Word Icon Detailed Word Document
Outlines how amwell aligns financial, customer, internal process, and learning priorities to drive strategic performance
Plus Icon
Excel Icon Editable Excel File
Provides a clear Balanced Scorecard view of Amwell to quickly pinpoint performance gaps across financial, customer, process, and growth priorities.

Drawbacks

Icon

Outcome Blur

Outcome blur is a real drawback for Amwell because its care sits inside payer and provider workflows, so better outcomes are hard to attribute to Amwell alone. The scorecard can overstate impact when a health system also changes staffing, triage, or follow-up, and understate it when those partners drive most of the gain. In 2025, that makes outcome metrics less clean than revenue or visit volume.

Icon

Data Gaps

Data gaps are a real drawback in Amwell's Balanced Scorecard because metrics can come from 2 or more client systems and from different visit types. If one client counts a completed visit and another counts a scheduled visit, the scorecard can look exact while still missing the real business picture.

This matters in 2025 because telehealth operators still manage fragmented data flows across payers, providers, and platforms, so small definition shifts can distort retention, utilization, and margin views. One bad definition can move a KPI without changing the underlying care result.

Explore a Preview
Icon

Usage Swings

Usage swings make Amwell's scorecard noisy: telehealth demand can jump with flu season, clinician coverage, and plan design, so one weak month can hide the real adoption trend. In 2025, that matters because even a 1-month dip can distort quarterly readouts and trigger the wrong call on sales or staffing. The fix is to track 3- and 12-month rolling volume, not just monthly bookings.

Icon

Long Payback

Long payback is a real drawback for Amwell because a Balanced Scorecard can reward near-term activity, while enterprise telehealth deals often take months to move from signed contract to live usage. In 2025, that lag still matters: implementation, clinician onboarding, and payer approval can delay revenue recognition and usage metrics even after a deal is closed. So a scorecard may show progress before cash flow and patient volume catch up. That can make execution look stronger than the business really is.

Icon

Policy Risk

Policy risk is a real weak spot for Amwell because telehealth pay rules can shift fast. In 2025, Medicare telehealth flexibilities were extended only through September 30, 2025, so demand and visit mix can change on short notice. State licensing rules can also limit where clinicians can see patients, which can hit revenue and margin if the scorecard only tracks internal metrics. A better Balanced Scorecard must watch policy changes as closely as utilization.

Icon

Amwell's KPIs Can Mislead as Policy Risk and Data Fragmentation Persist

Amwell's scorecard can blur outcomes because care results sit inside payer and provider workflows, so a lift may not belong to Amwell alone. In 2025, fragmented visit data, seasonal demand swings, and long enterprise payback can make monthly KPIs look better or worse than the real business. Policy risk stays high too: Medicare telehealth flexibilities ran only through September 30, 2025.

Drawback 2025 signal
Policy risk Medicare flexibilities through Sep 30, 2025

Preview Before You Purchase
amwell Reference Sources

This is the actual Amwell Balanced Scorecard analysis document you'll receive after purchase – no samples, no surprises, just the full report.

The preview below is taken directly from the complete file, so what you see here is exactly what you'll download after checkout.

It's a professional, ready-to-use Balanced Scorecard analysis built for clear insight and practical decision-making.

Explore a Preview

Frequently Asked Questions

It should measure access, quality, and retention first. For Amwell, the most practical scorecard connects 4 client groups, 3 communication modes, and 2 core outcomes: completed visits and contract renewal. That combination shows whether virtual care is actually being used, whether service quality holds up, and whether the platform is building durable revenue.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.